Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same
US11744823B2 · kind B2 · utility
0Cited by
9References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2021 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | Nov 19, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to pharmaceutical compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide useful as a selective inhibitor of c-kit kinase and uses of the same in the treatment of c-kit kinase associated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.